Literature DB >> 2632276

Endogenous oestrogens and androgens in normal and malignant endometrial and mammary tissues.

J H Thijssen1, M A Blankenstein.   

Abstract

Because of a well-established mechanism of action, tissue concentrations of steroid hormones are thought to be more closely related than blood levels to the biological effects exerted by these hormones. The results of studies on oestrogen and androgen concentrations in malignant and normal breast tissues are presented. Normal fatty and epithelial breast tissues and malignant tumour samples which had been obtained from pre- and postmenopausal women of two countries (Poland and The Netherlands) differing in the incidence of this malignancy were studied. In both countries highly comparable oestradiol concentrations in the breast were found. The median hormone levels in tumour tissue of 0.65 pmol/g tissue did not change with age. They were significantly higher than in normal epithelial (0.48 and 0.25 pmol/g in pre- and postmenopausal women) and fatty tissues (0.54 and 0.19 pmol/g respectively). Particularly in postmenopausal women, hormone levels in tumour tissue were much higher than plasma concentrations, which are comparable in both populations. Oestrone levels decreased with age in normal and malignant breast tissues. In both countries median levels in normal and fatty tissues of premenopausal women were similar (1.10 pmol/g tissue) but higher than those in postmenopausal patients (0.45 pmol/g tissue. Significantly lower levels were found in the malignant tissue samples of Polish premenopausal women (0.70 pmol/g) than in Dutch women (1.05 pmol/g); similarly, after menopause the tissue concentrations were higher in Dutch (0.55 pmol/g) than in Polish (0.31 pmol/g) patients. Thus lower oestrone tissue levels were observed in tumours from the country with the lower incidence for breast cancer. In a comparable study of uterine tissues, obtained from pre- and postmenopausal women, higher oestradiol concentrations than in the breast were found, whereas estrone levels were very similar. The levels in the uterus did not correlate with those in the plasma; no relation with histology was observed. The results of androgen measurements in breast tissues were in agreement with the concept that, particularly, androstenedione and testosterone could play a role as substrates for local aromatization. Lower concentrations were observed in the tumours than in the normal and fatty tissues. More extensive investigations will be needed to clarify the role of local formation (aromatization, hydrolysis by sulphatase) of oestrogens in tissues and of the interconversion of less active (oestrone) to more active (oestradiol) oestrogens.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2632276     DOI: 10.1016/0277-5379(89)90377-5

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  10 in total

1.  A signature of balancing selection in the region upstream to the human UGT2B4 gene and implications for breast cancer risk.

Authors:  Chang Sun; Dezheng Huo; Catherine Southard; Barbara Nemesure; Anselm Hennis; M Cristina Leske; Suh-Yuh Wu; David B Witonsky; Olufunmilayo I Olopade; Anna Di Rienzo
Journal:  Hum Genet       Date:  2011-06-10       Impact factor: 4.132

2.  SNP discovery, expression and cis-regulatory variation in the UGT2B genes.

Authors:  C Sun; C Southard; D Huo; R D Hernandez; D B Witonsky; O I Olopade; A Di Rienzo
Journal:  Pharmacogenomics J       Date:  2011-03-01       Impact factor: 3.550

Review 3.  New generation aromatase inhibitors in breast cancer. Weighing out potential costs and benefits.

Authors:  G M Higa
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

4.  Pre-diagnostic sex hormone levels and survival among breast cancer patients.

Authors:  Kevin H Kensler; A Heather Eliassen; Bernard A Rosner; Susan E Hankinson; Myles Brown; Rulla M Tamimi
Journal:  Breast Cancer Res Treat       Date:  2019-01-02       Impact factor: 4.872

5.  Passenger protein determines translocation versus retention in the endoplasmic reticulum for aromatase expression.

Authors:  Jasmeet Kaur; Himangshu S Bose
Journal:  Mol Pharmacol       Date:  2013-11-26       Impact factor: 4.436

6.  Tumor estrogen content and clinico-morphological and endocrine features of endometrial cancer.

Authors:  L M Berstein; A E Tchernobrovkina; V B Gamajunova; A J Kovalevskij; D A Vasilyev; O F Chepik; E A Turkevitch; E V Tsyrlina; S J Maximov; L A Ashrafian; J H H Thijssen
Journal:  J Cancer Res Clin Oncol       Date:  2003-04-15       Impact factor: 4.553

Review 7.  Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview.

Authors:  Chantal Guillemette; Alain Bélanger; Johanie Lépine
Journal:  Breast Cancer Res       Date:  2004-09-27       Impact factor: 6.466

8.  Pre-treatment high body mass index is associated with poor survival in Asian premenopausal women with localized breast cancer.

Authors:  Yung-Chang Lin; Hsiao-Hsiang Cheng; Shin-Cheh Chen; Wen-Chi Shen; Yi-Ting Huang
Journal:  J Cancer       Date:  2021-05-27       Impact factor: 4.207

9.  Androgen receptors and serum testosterone levels identify different subsets of postmenopausal breast cancers.

Authors:  Giorgio Secreto; Elisabetta Venturelli; Elisabetta Meneghini; Maria Luisa Carcangiu; Biagio Paolini; Roberto Agresti; Cristina Pellitteri; Franco Berrino; Massimo Gion; Patrizia Cogliati; Giuseppina Saragò; Andrea Micheli
Journal:  BMC Cancer       Date:  2012-12-14       Impact factor: 4.430

10.  Oestrone sulphatase activity in mammary tumours and the liver of N-nitrosomethylurea treated rats.

Authors:  T R Evans; S K Chander; M G Rowlands; R C Coombes
Journal:  Br J Cancer       Date:  1992-01       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.